Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT03575520

Completed

Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

Breast Cancer
NCT03567044

Unknown

Immune Effects in Patients Treated With Whole Breast Irradiation

Breast Cancer
NCT02666079

Unknown

The LightPath® Breast Cancer Study

Breast Cancer
NCT03541161

Completed

Early Rehabilitation After Immediate Reconstruction With TEI in Breast Cancer Patients

Breast Cancer
NCT03024463

Unknown

The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer Patients

Breast Neoplasm
NCT03474016

Unknown

Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast Cancer

Breast Cancer
NCT01582971

Completed

Home-Based Symptom Management Via Reflexology for Breast Cancer Patients

Breast Cancer
NCT01852032

Completed

Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis

Breast Cancer
NCT02505698

Withdrawn

A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment

Breast Cancer
NCT00559845

Completed

A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

Breast Cancer
NCT00824538

Terminated

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

Breast Cancer
NCT00090857

Completed

Letrozole in Preventing Breast Cancer in Postmenopausal Women (WISE)

Breast Cancer
NCT02831530

Completed

Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients (ABC-POP)

Breast Cancer
NCT00647582

Completed

Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast Cancer

Breast Cancer
NCT01142778

Completed

A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer (AVATAXHER)

Breast Cancer
NCT03081234

Withdrawn

Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer (EarLEE-2)

Breast Cancer
NCT03457467

Unknown

Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer

Breast Cancer
NCT02214004

Unknown

Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women (HERAKLES)

Breast Cancer
NCT01694225

Completed

Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

Breast Cancer
NCT01152606

Completed

A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin

Breast Cancer
NCT00864175

Terminated

Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer

Breast Cancer
NCT02591966

Unknown

Genetic Alteration After Systemic Treatment in Breast Cancer

Breast Cancer
NCT00853996

Completed

Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer

Breast Cancer
NCT00093795

Completed

Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer

Breast Cancer
NCT00148902

Completed

Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

Neoplasms, Breast
NCT03214419

Completed

Study First Step to Virtual Breast Cancer Localization (Anatobreast)

Breast Cancer
NCT00855114

Withdrawn

Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Breast Cancer
NCT00680667

Completed

Clinical Trial of Trametes Versicolor in Women With Breast Cancer

Breast Cancer
NCT03350854

Completed

Improving Decision Role Concordance in Newly Diagnosed Breast Cancer Patients

Breast Cancer
NCT00996762

Completed

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Neoplasms, Breast
NCT00821054

Completed

A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients

Neoplasms, Breast
NCT01386411

Completed

Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer

Breast Cancer
NCT01669252

Completed

Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer (NeoEribulin)

Breast Cancer
NCT00581256

Completed

A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer

Breast Cancer
NCT00581529

Terminated

Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy

Breast Cancer
NCT03319069

Unknown

Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer

Breast Cancer
NCT01187381

Terminated

An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (HERODOT)

Breast Cancer
NCT01831778

Completed

Breast Cancer Surveillance Consortium (BCSC)

Breast Cancer
NCT02395575

Completed

A Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay

Breast Cancer
NCT00813878

Terminated

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

Breast Cancer
NCT03302819

Unknown

London Investigation Into diElectric Scanning of Lesions (LIESL)

Breast Cancer
NCT02934126

Completed

The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer (M16SDM)

Breast Cancer
NCT00859651

Completed

Vitamin D in Postmenopausal Women at High Risk for Breast Cancer

Breast Cancer
NCT00408408

Unknown

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Breast Cancer
NCT02300675

Completed

Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy (PEPs HORMONO)

Breast Cancer
NCT01864083

Completed

FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients

Breast Cancer
NCT00483223

Completed

Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response

Breast Cancer
NCT01712893

Completed

Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer

Breast Cancer
NCT00900744

Completed

A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6

Breast Cancer
NCT00991263

Completed

Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations